Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nanjing Yoko Biomedical Co., Ltd.

Clinical trials sponsored by Nanjing Yoko Biomedical Co., Ltd., explained in plain language.

Not yet recruiting 1

New antibiotic YK-1169 takes on deadly hospital pneumonia

Disease control Not yet recruiting

This Phase 3 trial tests a new antibiotic called YK-1169 against a standard treatment (ceftazidime-avibactam) for adults with pneumonia caught in the hospital or from a ventilator. About 590 participants will receive either drug for 7-14 days. The main goal is to see if YK-1169 l…

Phase 3 • Sponsor: Nanjing Yoko Biomedical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC